crystallisation

The control of crystal size distribution (CSD) in pharmaceutical crystallization is of primary importance, as downstream processes such as filtration or drying are greatly affected by the properties...

Polymorphism and crystallisation are considered to be one of the most significant and demanding areas of pharmaceutical development. New discoveries have the potential to either give organisations a...

“Continuous manufacturing is done in almost all manufacturing industries, except for wine, hard spirits, and pharmaceuticals. Defining a batch is up to the manufacturer but consistent with QbD...

Polymorphism and crystallisation are among the most important and challenging areas of pharmaceuticals today, with new polymorph discoveries harbouring the potential to dramatically change the prope...

In this podcast Dr. Nair Rodriguez-Hornedo, Professor, Department of Pharmaceutical Sciences at the University of Michigan, speaks to Andrea Charles from Pharma IQ, about how can we improve pharmaceut...

There has been increased focus on using crystals and the ever-changing, sometimes disappearing properties of polymorphs as significant scientific and business opportunities.  IQPC’s Polymor...

Dr. Vaibhav Sihorkar, Head of Pharmaceutical Development at Aurigene Discovery Technologies in India, gave Pharma IQ his insights on existing challenges to co-crystal commercialisation. Wha...

The perfect ingredients and compounds help to make many drugs effective, but the very best medicines developed by the pharmaceutical sector are also formulated to react in the most suitable way once...